Brief: China Biotech Services Says Capital Injections Into Shanghai Longyao Biotech
08/12/2023 15:51
Dec 8 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* YIXING HUANKE PRODUCT DEVELOPMENT EQUITY INVESTMENT
ENTERPRISE
AGREED TO MAKE CAPITAL INJECTION OF RMB48 MILLION
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)